Research News
View articles by month and year
1–3 of 3 articles
-
FDA Warning: Reclast May Cause Severe Kidney Problems
On Sept. 1, 2011 the U.S. Food and Drug Administration warned doctors and patients that Reclast may cause severe kidney problems.
-
Oral Bisphosphonates May Reduce Risk for Postmenopausal Women
Two studies suggest that oral bisphosphonates may reduce the risk of invasive breast cancer in postmenopausal women by 30% to 40%.
-
Bisphosphonates Seem to Reduce Risk
A new study found a strong association between taking oral bisphosphonates and a lower risk of breast cancer.
1–3 of 3 articles
